What It Is PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide analogue derived from Melanotan II, acting as a non-selective agonist at melanocortin receptors — specifically MC1R, MC3R, MC4R, and MC5R. Unlike traditional vasodilatory compounds, PT-141 exerts its effects centrally through the hypothalamus and limbic system via MC3R and MC4R activation, influencing neurological pathways associated with sexual arousal and autonomic response. It does not act on the vascular system directly. The melanocortin system has broad implications in appetite regulation, energy homeostasis, and autonomic nervous system modulation in addition to sexual function research.
How It Is Used PT-141 is reconstituted with bacteriostatic water and administered via subcutaneous injection. Research applications include neuroendocrinology, melanocortin receptor pharmacology, sexual dysfunction modelling, and central nervous system arousal pathway studies.
All Genovare products are manufactured in-house under strict quality control protocols, utilizing the highest grade synthesis methods, third-party purity verification, and rigorous sterility standards to ensure consistent, research-grade output in every batch.
This site is for informational purposes only and does not constitute medical advice. These products are not for sale.
Choosing a selection results in a full page refresh.
